Ling Leung resumes & CV records
Resumes
Ling Leung
Ling M Leung, 511069 Saginaw Ter UNIT 202, Sunnyvale, CA 94089
Ling Leung Phones & Addresses
1069 Saginaw Ter UNIT 202, Sunnyvale, CA 94089
San Francisco, CA
San Jose, CA
Santa Clara, CA
Madison, WI
Fremont, CA
Alameda, CA
Mountain View, CA
Central Islip, NY
Selden, NY
Mentions for Ling M Leung
Publications & IP owners
Us Patents
Triple Combination Antibody Therapies
US Patent:
2019001, Jan 10, 2019
Filed:
Jun 1, 2018
Appl. No.:
15/996369
Inventors:
- Holon, IL
Ling Leung - Foster City CA, US
Sarah Whelan - Mountain View CA, US
Maya Kotturi - Belmont CA, US
Eran Ophir - Yehuda, IL
Arthur Machlenkin - Givaat Brener, IL
Zoya Alteber - Nes Ziyona, IL
Meir Azulay - Givatayim, IL
Sandeep Kumar - San Bruno CA, US
Radhika Desai - Brisbane CA, US
Christopher Chan - South San Francisco CA, US
Kathryn Logronio - Pleasanton CA, US
Ling Leung - Foster City CA, US
Sarah Whelan - Mountain View CA, US
Maya Kotturi - Belmont CA, US
Eran Ophir - Yehuda, IL
Arthur Machlenkin - Givaat Brener, IL
Zoya Alteber - Nes Ziyona, IL
Meir Azulay - Givatayim, IL
Sandeep Kumar - San Bruno CA, US
Radhika Desai - Brisbane CA, US
Christopher Chan - South San Francisco CA, US
Kathryn Logronio - Pleasanton CA, US
International Classification:
C07K 16/30
A61P 35/00
A61P 35/00
Abstract:
The present invention is directed to triple combination therapies with anti-TIGIT antibodies, anti-PVRIG antibodies, and checkpoint inhibitors, including anti-PD-1 or anti-PD-L1 antibodies.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.